Strata skin sciences announces theraclear®x product demonstration at inaugural winter clinical conference

Horsham, pa., feb. 16, 2023 (globe newswire) -- strata skin sciences, inc. (nasdaq: sskn), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that joel l. cohen, md (faad, facms), director of aboutskin dermatology in greenwood village, colorado, will be speaking during the live patient demonstration of the theraclear®x device, fda-cleared for the treatment of mild-to-moderate acne, including comedonal, pustular, and inflammatory acne vulgaris, at the inaugural winter clinical conference at the intercontinental in miami, florida from february 17-20, 2023. details for the demonstration are found below:
SSKN Ratings Summary
SSKN Quant Ranking